In March 2025, the company announced new options to get a direct-to-shopper supplying of its Wegovy weight loss drug. The company proven a new pharmacy, termed NovoCare, which might charge clients $499 per month for use of the drug, less than half the cost of the drug by way of other pharmaceutical distribution networks.[53]Scientific tests of Rybe